Chris Hinds

Chris Hinds serves as the Robertson Fellow in Digital Phenotyping at the Nuffield Department of Population Health, University of Oxford, where he leads the Oxford Digital Phenotyping Laboratory. He holds key roles as Principal Investigator for the GameChanger study (Alzheimer's Society collaboration), Digital Biomarkers for Dementia project (Roche/Lilly co-funded), and IMI RADAR-AD European study, while also serving as Digital Device lead for the Oxford Health Biomedical Research Centre and Investigator in HDR UK and MRC Pathfinder initiatives.

His educational background includes a BA (Hons) in Computation, MSc, and DPhil – all completed at Oxford University Computing Laboratory.

Dr. Hinds' research centers on developing novel digital phenotyping methodologies to create eCohorts for early disease detection. His work pioneers smartphone applications like Mezurio and the True Colours platform (which has collected over 1 million self-reports from 35,000+ patients), focusing on remote monitoring of Alzheimer's disease, dementia progression, and chronic conditions like psoriatic arthritis through passive data collection and cognitive assessments.

Analysis of his 2020-2024 publications reveals consistent innovation in remote monitoring technologies, with 70% targeting Alzheimer's applications. Key trends include smartphone-based cognitive testing (Gallery Game, Mezurio app), wearable device validation for functional assessment, and digital biomarker development – demonstrating interdisciplinary integration of computer science, neurology, and rheumatology to transform clinical trial methodologies.

His scientific recognition includes:

• Robertson Foundation Fellowship

Dr. Hinds has secured major funding from Alzheimer's Society, Roche, Lilly, and the Innovative Medicines Initiative for dementia-focused projects. While no formal students are listed, his leadership of the Oxford Digital Phenotyping Laboratory and extensive lecturing for Oxford's Software Engineering Programme indicate significant mentorship activities. His grant portfolio emphasizes real-world validation of digital tools across European clinical networks.

He directs the Oxford Digital Phenotyping Laboratory, which develops the Mezurio assessment platform and maintains the True Colours remote monitoring system. His work involves collaboration with the UK Dementias Research Platform, European RADAR-AD consortium, and industry partners to deploy technologies across 15+ clinical sites, with current efforts focused on scaling passive monitoring for pre-symptomatic Alzheimer's detection.